Top Qs
Timeline
Chat
Perspective
Avner Halperin
Israeli entrepreneur From Wikipedia, the free encyclopedia
Remove ads
Avner Halperin (Hebrew: אבנר הלפרין) is an Israeli entrepreneur and CEO of Sheba Impact - the entrepreneurship and innovation company of Sheba Medical Center. He is also EyeControl's Chairman of the Board of Directors, a Senior Fellow at Harvard Kennedy School,[1] and an adjunct professor at Tel Aviv University (teaching the AI & Big Data Economics Course).[2]
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (May 2025) |
Remove ads
Biography
Avner Halperin was born and raised in Jerusalem, Israel. He spent the last six years of his schooling in the United States,[3] attending high school in Washington, D.C.[4] After high school, he served in the IDF.[3][5] He earned a B.Sc. in physics from the Hebrew University of Jerusalem and, later, an M.Sc. in the subject from Tel Aviv University.[4] He earned an MBA through the Sloan Fellows program at MIT, where his thesis documented the role of American CEOs in Israeli companies.[4][5]
Remove ads
Business and academic career
Summarize
Perspective
Halperin worked in executive positions at Eldat Communications, Radcom, and Lenslet. He also served as the CEO of Emmunet, which he co-founded with Yossi Vardi. In 2004, he co-founded EarlySense, a medical technology company, with Yossi Gross, Guy Shinar, and Danny Lange. On February 1, 2021, EarlySense technology was acquired by Hill-Rom, Baxter.[6]
He is an inventor of 34 U.S. patents many of which are associated with non-contact medical detection and monitoring devices (other patents cover wireless communications and cyber security solutions).
In 2016, Halperin was a member of the Israeli Economic Development Mission led by Governor Charlie Baker.[7][8]
In 2020, Halperin was appointed EyeControl's chairman of the board of directors.[9]
In addition, Halperin is an adjunct professor at the Tel Aviv University[10] and gave lectures at numerous events.[11][12][13][14]
In 2022, Halperin led a team of researchers at Harvard Kennedy School that published a model to promote technology ecosystems in the Middle East.[15][16]
In 2024, Halperin led a team of researchers at the MIddle East Initiative of Harvard Kennedy School that published a report on the role of health initiatives in building collaborations between Israelis and Palestinians [17]. The New England Journal of Medicine published a perspective article co-authored by Halperin about that research.[18]
Remove ads
Published works
- Comment on Compact short-wavelength free-electron laser, A. Gover and A. Halperin, Physical Review Letters 67, 1934, September 1991.[19]
- Non-classical Effects in Smith-Purcell Radiation, Tel-Aviv University, 1993.[20]
- Electron-beam-induced super-radiant emission from a grating, A. Halperin, A. Gover, and A. Yariv, Physical Review A 50, 3316, October 1994.[21]
- Globally dispersed startups, A. Halperin, MIT, 2001.[22]
- Time to Reboot: A Blueprint for the Palestinian Tech Sector, A. Halperin, M. Khweis, E. Sandler, Harvard, 2022[23]
- A blockchain-based computerized network infrastructure for the transparent, immutable calculation and dissemination of quantitative, measurable parameters of academic and medical research publications, Segal, G., Martsiano, Y., Markinzon, A., Mayer, A., Halperin, A., & Zimlichman, E., Digital Health 9, 2023 [24]
- Halperin, Avner, Yasmeen Abu Fraiha and Noam Alon. “A Healthcare Bridge over Troubled Conflicts: A New Model for Building Trust through Joint Healthcare Programs.” November 2024[25]
- Halperin, Avner, Yasmeen Abu Fraiha and Noam Alon. “Health Care Bridges — Pathways toward Trust in Gaza and Beyond.” New England Journal of Medicine, March 22, 2025[18]
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads